Tánaiste announces major expansion of Cook Medical in Limerick with 200 new jobs and ¤25 million investment
Irish Facility to be the sole global manufacturing site for new stent product
Tánaiste and Minister for Enterprise, Trade and Employment Mary Coughlan TD today (Tuesday 30th September 2008) announced that Cook Medical, one of the world’s largest privately held medical device companies, is to invest ¤25 million, with the support of Government through IDA Ireland, in the expansion of its medical devices manufacturing and services facility - Cook Ireland Limited - in Limerick. The investment will add 200 high quality jobs over the next five years. It will also establish the Limerick operation as the sole global manufacturing site for Cook’s new drug eluting stent, Zilver PTX, for the treatment of peripheral arterial disease. This is the first time such a stent will be manufactured in Ireland.
Cook Ireland Limited established in the National Technology Park, Limerick, in 1996 where it currently employs 480 people in the production of devices for a range of medical areas including urology, gastroenterology, women’s health and surgery. A number of European management roles are housed at the facility and the diverse range of manufacturing and services activities performed there include customer services, sales support, marketing, production, regulatory, distribution and R&D.
The Tánaiste, welcoming the investment, said “Today’s news is another fantastic development for the thriving medical technology industry in Ireland. This is the 10th significant investment by a multinational company from the medical technologies sector in Ireland since the beginning of this year.”
“It is superb news for the staff and management of Cook Ireland. The Irish facility has secured the manufacturing investment for a leading-edge product and will result in 200 new jobs in the company. Cook is a great company and its medical device products are at the forefront of technology. Since establishing in Limerick in 1996, the operation has seen continuous development well beyond its original mandate and this investment will add further strategic value and importance to the facility. The company has also undertaken collaborative R&D with University of Limerick and Dublin Institute of Technology, an area in which this Government is fully supportive’” the Tánaiste concluded.
Bill Doherty, Vice President of Cook’s European business said “The Limerick facility’s successful track-record in implementing and delivering a variety of projects over the past 12 years was a significant factor in Cook’s decision to undertake this strategic investment at the site. As the investment forms part of our company’s future international growth plans, it is essential that we have confidence in the ability of the chosen location to deliver to the strict deadlines and exacting quality standards required. We have that confidence in the Limerick team. In addition, our experience in Limerick demonstrates Ireland’s ability to provide the right people - highly skilled and adaptable which are needed for the next phase of our development.”
ENDS/ETE1944
Notes for Editors:
Cook Medical
Cook Medical was one of the first companies to help popularise interventional medicine, pioneering many of the devices now commonly used worldwide to perform minimally invasive medical procedures. Today, the company integrates minimally invasive medical device design, biopharma, gene and cell therapy and biotech to enhance patient safety and improve clinical outcomes in the fields of aortic intervention; interventional cardiology; critical care medicine; gastroenterology; radiology, peripheral vascular, bone access and oncology; surgery and soft tissue repair; urology; and assisted reproductive technology, gynecology and high-risk obstetrics.Founded in 1963 and operated as a family-held private corporation, Cook is a past winner of the prestigious Medical Device Manufacturer of the Year Award from Medical Device & Diagnostic Industry magazine. It has subsidiary companies in North America, Europe, Asia and Australia. For 2007 revenues for Cook Group were $1.25 billion up 19% on 2006, and it invested $108.7 million on R&D.
For more information, visit www.cookmedical.com
For further information about this announcement contact:
Cook Medical:
Anna Gueldenhaupt/ Lucie Smith, Racepoint Group +44 (0) 20 8752 3215 / 3211 anna.gueldenhaupt@racepointgroup.com / lucie.smith@racepointgroup.com
Dave McCarty, Director of PR. Tel: +1 (812) 339 2235 or +1 (812) 322 1805 (mob)
Bill Doherty, MD Cook Ireland Tel: 061 334440
IDA Ireland:
Regional Media: Sean Denvir, Manager South-West Region Tel: 087 231 9471 (mob)
National Media: Ruth Croke, Press & PR Manager. Tel: 087 4195051 Ruth.Croke@IDA.ie
Last modified: 30/09/2008
| © 2012 Department of Jobs, Enterprise and Innovation | Privacy Statement |